β2-agonists in acute asthma: The evolving state of the art

Pediatric Emergency Care

Volumn 18, Issue 6, 2002, Pages 442-447

  Scarfone, Richard J ^a,b   Friedlaender, Eron Y ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

2 Agonists; Acute asthma; Ipratropium bromide; Levalbuterol; Metered dose inhaler; Small volume nebulizer

Indexed keywords

ADRENALIN; ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; LEVALBUTEROL; PREDNISONE; SALBUTAMOL; TERBUTALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ACUTE DISEASE; ASTHMA; CHILD; CLINICAL TRIAL; CONTINUING EDUCATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL NEBULIZER; METERED DOSE INHALER; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; COMPARATIVE STUDY; INFUSION; NEBULIZER;

ACUTE DISEASE; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS; INFUSIONS, PARENTERAL; IPRATROPIUM; NEBULIZERS AND VAPORIZERS;

EID: 0036882341     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006565-200212000-00010     Document Type: Review

References (61)

1. Schuh S, Parkin P, Rajan A, et al. High-versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics 1989;83:513-518.
2. Schuh S, Reider MJ, Canny G, et al. Nebulized albuterol in acute childhood asthma: Comparison of two doses. Pediatrics 1990;86:509-513.
3. Murphy S. Guidelines for the Diagnosis and Management of Asthma (report no. 91-3042). Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, 1997.
4. 2-selective sympathomimetics [abstract]. Pulm Pharmacol 1994;151:A274.
5. Johansson F, Rydberg I, Aberg G, et al. Effects of albuterol enantiomers on in vitro bronchial reactivity. Clin Rev Allergy Immunol 1996;14:57-64.
6. Templeton AGB, Chapman ID, Chilvers ER, et al. Effects of S-salbutamol on human isolated bronchus. Pulm Pharmacol 1998;11:1-6.
7. Volcheck GW, Gleich GJ, Kita H. Pro- and anti-inflammatory effects of beta adrenergic agonists on eosinophil response to IL-5. J Allergy Clin Immunol 1998;101:S35.
8. Leff AR, Herrnreiter A, Naclerio RM, et al. Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils. Pulm Pharmacol Ther 1997;10:97-104.
9. Yamaguchi H, McCullough JR. S-Albuterol exacerbates calcium responses to 1-carbachol in airway smooth muscle cells. Clin Rev Allergy Immunol 1996;14:47-55.
10. Mitra S, Ugur M, Ugur O, et al. (S)-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle. Mol Pharmacol 1998;53:347-354.
11. Dhand R, Goode M, Reid R, et al. Preferential pulmonary retention of S-albuterol after inhalation of racemic albuterol. Am J Resp Crit Care Med 1999;160:1136-1141.
12. Lipworth BJ, Clark DJ, Koch P, et al. Pharmacokinetics and extrapulmonary beta 2 receptor activity of nebulized racemic salbutamol and its R and S isomers in healthy volunteers. Thorax 1997;52:849-852.
13. Cockcroft DW, Swystun VA. Effects of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine. Thorax 1997;52:845-848.
14. Nelson HS, Bensch G, Pleskow WW, et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol 1998;102:943-952
15. Gawchick SM. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients. J Allergy Clin Immunol 1999;103:615-651.
16. Milgrom H, Skoner DP, Bensch G, et al. Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol. J Allergy Clin Immunol 2001;108:938-945.
17. Ahrens R, Weinberger M, Levalbuterol and racemic albuterol: Are there therapeutic difference? J Allergy Clin Immunol 2001;108:1-6.
18. Lotvall J, Palmqvist M, Arvidsson P, et al. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients. J Allergy Clin Immunol 2001;108:726-731.
19. Carl JC, Myers T, Kercsmar CM. Comparison of levalbuterol and racemic albuterol for treatment of acute asthma in the emergency department [abstract]. Pediatr Emerg Care 2001;17:317-318.
20. Levalbuterol for asthma. Med Lett 1999;41:51-53.
21. Ducharme FM, Davis GM. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma. J Pediatr 1998;133:479-485.
22. Schuh S, Johnson DW, Callahan S, et al, Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr 1995;126:639-645.
23. Qureshi F, Pestian J, Davis P, et al. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 1998;339:1030-1035.
24. Zorc JJ, Pusic MV, Ogborn CJ. Ipratropium bromide added to asthma treatment in the pediatric emergency department. Pediatrics 1999;103:748-752.
25. Tien I, Dorfman D, Kastner B, et al. Metered-dose inhaler: The emergency department orphan. Arch Pediatr Adolesc Med 2001;155:1335-1339.
26. Rubilar L, Castro-Rodriguez JA, Girardi G. Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age. Pediatr Pulmonol 2000;29:264-269.
27. Amirav I, Newhouse MT. Metered-dose inhaler accessory devices in acute asthma. Arch Pediatr Adolesc Med 1997;151:876-882.
28. Freelander M, Van Asperen PP. Nebuhaler versus nebulizer in children with acute asthma. BMJ 1984;288:1873-1874.
29. Fuglsang G, Pedersen S. Comparison of Nebuhaler and nebulizer treatment of acute severe asthma in children. Eur J Respir Dis 1986;69:109-113.
30. Pendergast J, Hopkins J, Timms B, et al. Comparative efficacy of terbutaline administered by Nebuhaler and by nebulizer in young children with acute asthma. Med J Aust 1989;151:406-408.
31. Ba M, Spier S, Lapierre G, et al. Wet nebulizer versus spacer and metered-dose inhaler via tidal breathing. J Asthma 1989;26:355-358.
32. Lee N, Rachelefsky G, Kobayashi RH, et al. Comparison of efficacy and safety of albuterol administered by power-driven nebulizer (PDN) versus metered-dose inhaler (MDI) with Aerochamber and mask in young children with asthma [abstract]. J Allergy Clin Immunol 1991;87:307.
33. Kerem E, Levison H, Schuh S, et al. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr 1993;123:313-317.
34. Lin YZ, Hsieh KH. Metered dose inhaler and nebulizer in acute asthma Arch Dis Child 1995;72:239-240.
35. Parkin PC, Saunders NR, Diamond SA, et al. Randomised trial spacer v nebuliser for acute asthma. Arch Dis Child 1995;72:239-240.
36. Chou KJ, Cunningham SJ, Crain EF. Metered-dose inhalers with spacers vs nebulizers for pediatric asthma. Arch Pediatr Adolesc Med 1995;72:239-240.
37. Williams JR, Bothner JP, Swanton RD. Delivery of albuterol in a pediatric emergency department. Pediatr Emerg Care 1996;12:263-267.
38. Ploin D, Chapuis FR, Stamm D, et al. High-dose albuterol by metered-dose inhaler plus a spacer device versus nebulization in preschool children with recurrent wheezing: A double-blind, randomized equivalence trial. Pediatrics 2000;106:311-317.
39. Wildhaber J, Dore ND, Wilson JM, et al. Inhalation therapy in asthma: Nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr 1999;135:28-33.
40. Raimondi A, Schottlender J, Lombardi D, et al, Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. Chest 1997;112:24-28.
41. Rodrigo C, Rodrigo G. Salbutamol treatment of acute severe asthma in the ED: MDI vs hand-held nebulizer. Am J Emerg Med 1998;16:637-642.
42. Idris AH, McDermott MF, Raucci JC, et al. Emergency department treatment of severe asthma: Metered dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest 1993;103:665-672.
43. Camargo CA Jr, Kennedy PA. Assessing costs of aerosol therapy. Respir Care 2000;45:756-763.
44. Dewar A, Stewart A, Cogswell J, et al. A randomized controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital. Arch Dis Child 1999;80:421-423.
45. Leversha A, Campanella S, Aickin R, et al. Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma. J Pediatr 2000;136:497-502.
46. Tal A, Golan H, Graver N, et al. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr 1996;128:479-482.
47. Clay MM, Pavia D, Newman SP, et al, Assessment of jet nebulisers for lung aerosol therapy. Lancet 1983;2:592-594.
48. Hess D, Horney D, Snyder T. Medication-delivery performance of eight small-volume, hand-held nebulizers: Effects of diluent volume, gas, flow rate, and nebulizer model. Respir Care 1989;34:717-723.
49. Wood JA, Wilson RSE, Bray C. Changes in salbutamol concentration in the reservoir solution of a jet nebulizer. Br J Dis Chest 1986;80:164-169.
50. Clay MM, Pavia D, Newman SP, et al. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax 1983;38:755-759.
51. Douglas JG, Leslie MJ, Brompton GK, et al. Is the flow rate used to drive a jet nebuliser clinically important [letter]? Br Med J Clin Res 1985;290:29.
52. Wiley JF II, Spiller HA, Krenzelok EP, et al. Unintentional albuterol ingestion in children. Pediatr Emerg Care 1994;10:193-196.
53. Schuh S, Johnson DW, Stephena D, et al. Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr 1999;135:22-27.
54. Berg E. In vitro properties of pressurized metered dose inhalers with and without spacer devices. J Aer Med 1995;8(suppl 3):S3-S11.
55. Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993;21:1479-1486.
56. Khine H, Fuchs SF, Saville AL. Continuous vs intermittent nebulized albuterol for emergency management of asthma. Acad Emerg Med 1996;3:1019-1024.
57. Rudnitsky GS, Eberlein RS, Schoffstall JM, et al. Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department. Ann Emerg Med 1993;22:1842-1846.
58. Lin RY, Sauter D, Newman T, et al. Continuous versus intermittent albuterol nebulization in the treatment of acute asthma. Ann Emerg Med 1993;22:1847-1853.
59. Besbes-Ouanes L, Nouira S, Elatrous S, et al. Continuous versus intermittent nebulization of salbutamol in acute severe asthma: A randomized, controlled trial. Ann Emerg Med 2000;36:198-203.
60. Katz RW, Kelly HW, Crowley MR, et al. Safety of continuous nebulized albuterol for bronchospasm in infants and children. Pediatrics 1993;92:666-669.
61. Travers A, Jones AP, Kelly K, et al. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev 2001;2:CD002988.